Report: Financial conflicts sway studies of flu fighters Tamiflu and Relenza
Billion is taxpayer monies have been spent on ineffective, dangerous and destroyed inventories (reported in the NY Times and The Wall Street Journal) on Tamiflu with no accountability or correction whatsoever.
~ Uncle Russ
A debate has raged over the past couple of years over whether world governments are wasting money by stockpiling Roche’s ($RHHBY) Tamiflu and GlaxoSmithKline’s ($GSK) Relenza to help combat a potential flu epidemic. At issue is a tough question: Are the drugs effective enough to justify the estimated $2 billion spent to stockpile them?